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Salmonella enterica serovar Schwarzengrund strains can cause salmonellosis in humans and infections in other animal species ([@B1]). The spread of multidrug-resistant *S.* Schwarzengrund from imported food products to humans has been reported ([@B1]). *S.* Schwarzengrund strains isolated from imported food products have been found to display a high level of resistance to fluoroquinolones ([@B2]). Furthermore, the production of extended-spectrum β-lactamase (ESBL), including carbapenemase (KPC-2), by *S*. Schwarzengrund has been found in different countries, which concerns observers ([@B3][@B4][@B5]). ESBL genes are often encoded on plasmids ([@B3], [@B4], [@B6]), which can facilitate their rapid transfer among Gram-negative pathogens, and this has created a major public health concern. Therefore, monitoring antimicrobial resistance (AMR) dynamics and characterization of mobile genetic elements, including plasmids of *S.* Schwarzengrund isolated from domestic and imported foods, food animals, and humans, is important. In the present study, whole-genome sequencing analyses of *S*. Schwarzengrund isolates from clinical sources will facilitate the study of AMR and resistance transmission.

Twenty-seven *S*. Schwarzengrund isolates from clinical sources were collected from the Minnesota Department of Health (Saint Paul, MN) and sequenced at the Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration (Jefferson, AR). Epidemiological information for these isolates is listed in [Table 1](#tab1){ref-type="table"}.

###### 

Whole-genome sequencing analyses of *Salmonella* Schwarzengrund isolates from clinical sources

  Strain no.   Source of isolate     Yr of isolation   No. of sequence reads   *N*~50~ value (bp)   No. of contigs   Assembly size (bp)   No. of CDSs   G+C content (%)   GenBank accession no.
  ------------ --------------------- ----------------- ----------------------- -------------------- ---------------- -------------------- ------------- ----------------- -------------------------------------------------------------------
  MDH-1        Blood                 2003              4,813,548               255,417              61               4,771,771            4,845         52.2              [QZET00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZET00000000)
  MDH-2        Stool                 2003              3,729,214               340,162              56               4,775,162            4,828         52.2              [QZES00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZES00000000)
  MDH-3        Stool                 2004              3,706,472               112,364              100              4,684,005            4,717         52.1              [QZER00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZER00000000)
  MDH-4        Stool                 2004              3,221,282               167,201              80               4,674,736            4,715         52.1              [QZEQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZEQ00000000)
  MDH-5        Stool                 2004              4,754,358               149,628              118              4,715,784            4,767         52.0              [QZEP00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZEP00000000)
  MDH-6        Stool                 2005              3,945,558               138,815              101              4,774,615            4,854         52.2              [QZEO00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZEO00000000)
  MDH-7        Stool                 2005              4,316,768               93,969               128              4,775,144            4,853         52.2              [QZEN00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZEN00000000)
  MDH-8        Stool                 2006              2,438,762               91,707               158              5,117,666            5,291         51.6              [QZEM00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZEM00000000)
  MDH-9        Stool                 2007              3,737,938               85,408               119              4,700,238            4,787         52.0              [QZEL00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZEL00000000)
  MDH-10       Stool                 2007              4,576,284               102,545              106              4,693,974            4,766         52.0              [QZEK00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZEK00000000)
  MDH-11       Stool                 2008              4,129,638               389,856              43               4,722,650            4,752         52.2              [QZFD00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFD00000000)
  MDH-12       Stool                 2009              4,399,374               230,080              54               4,706,223            4,745         52.1              [QZFE00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFE00000000)
  MDH-13       Stool                 2010              4,764,064               310,035              49               4,739,724            4,806         52.1              [QZFF00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFF00000000)
  MDH-14       Blood                 2011              3,208,474               312,411              51               4,767,578            4,829         52.2              [QZFG00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFG00000000)
  MDH-15       Stool                 2011              2,124,138               177,815              85               4,766,481            4,829         52.2              [QZMP00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZMP00000000)
  MDH-16       Stool                 2012              1,892,712               153,861              67               4,800,611            4,894         52.0              [QZFH00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFH00000000)
  MDH-17       Stool                 2012              1,532,044               123,253              100              4,802,467            4,863         52.0              [QZFI00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFI00000000)
  MDH-18       Gallbladder           2013              3,806,536               75,786               162              4,881,277            5,005         52.1              [QZFJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFJ00000000)
  MDH-19       Urine                 2013              2,291,464               60,132               201              4,775,923            4,879         52.2              [QZFK00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFK00000000)
  MDH-20       Subhepatic aspirate   2013              2,936,934               69,988               168              4,888,146            5,028         52.1              [QZFL00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFL00000000)
  MDH-21       Stool                 2014              2,343,572               57,255               195              4,688,259            4,773         52.1              [QZFM00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFM00000000)
  MDH-22       Stool                 2014              2,023,560               59,303               176              4,687,016            4,762         52.1              [QZMQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZMQ00000000)
  MDH-23       Urine                 2014              1,872,516               52,555               195              4,690,085            4,776         52.1              [QZFN00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFN00000000)
  MDH-24       Stool                 2014              2,607,656               53,183               197              4,682,121            4,730         52.2              [QZMR00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZMR00000000)
  MDH-25       Stool                 2015              2,424,548               35,368               313              4,778,730            4,868         52.1              [QZFO00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFO00000000)
  MDH-26       Urine                 2016              3,795,856               36,628               274              4,807,879            4,944         52.0              [QZFP00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFP00000000)
  MDH-27       Stool                 2016              2,566,758               54,067               225              4,807,042            4,891         52.0              [QZFQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/QZFQ00000000)

Stool samples were plated on Hektoen enteric agar, salmonella-shigella agar, and enrichment broths (Becton, Dickinson and Company \[BD\], Franklin Lakes, NJ). The plate or broth was then incubated at 35°C for 18 to 24 h. Colonies that were suspiciously lactose negative and positive for H~2~S were subsequently inoculated in motility-indole-lysine agar, triple sugar iron agar, and a urea agar plate (BD). Identification was confirmed using matrix-assisted laser desorption ionization--time of flight mass (MALDI-TOF) spectrometry. Likewise, blood and other clinical isolates were identified using standard microbiological procedures.

The total bacterial DNA was extracted with a DNeasy blood and tissue kit (Qiagen, Valencia, CA), and DNA sequencing libraries were constructed with the Nextera XT DNA library preparation kit (Illumina, San Diego, CA). Samples were multiplexed with a unique combination of two indexes of the Nextera XT index kit. Whole-genome sequencing (WGS) reactions were carried out on an Illumina MiSeq instrument with a 2 × 300 paired-end format ([@B7]). Trimming and *de novo* assembly were performed with CLC Genomics Workbench (v. 9, Qiagen, Germantown, MD). Genome sequences from individual samples were examined simultaneously with individual annotation tools, such as Rapid Annotation using Subsystem Technology (RAST) ([@B8]) and Pathosystems Resource Integration Center (PATRIC) ([@B9]), to cross-examine the sequence data. Subsequently, sequences were submitted to the NCBI using the WGS submission portal for final annotation with the Prokaryotic Genome Automatic Annotation Pipeline (PGAAP) ([@B10]) ([Table 1](#tab1){ref-type="table"}). The number of contigs, assembly size, coding sequences (CDSs), and G+C contents of each sample included in [Table 1](#tab1){ref-type="table"} were annotated with PATRIC. Annotation performed with the PGAAP was used as the final annotation available in the NCBI. We applied default settings for the bioinformatic software tools used for sequence trimming, *de novo* assembly, and annotation of the sequences.

Among 27 *S.* Schwarzengrund clinical isolates, PlasmidFinder ([@B11]) analyses showed that four of the isolates contained plasmids of identified incompatibility (Inc) groups. MDH-8 contained the IncHI2 and IncHI2A plasmids, and MDH-18, MDH-20, and MDH-25 contained the IncI1 plasmid. ResFinder ([@B12]) analyses showed that MDH-8 contained the *aph*(*6*)*-Id*, *strA*, and *tet*(B) resistance genes; MDH-18 and MDH-20 contained the *aph*(*3′*)*-Ia* and *bla*~CMY-2~ genes; and MDH-25 contained the *aac*(*3*)*-VIa*, *aadA1*, and *sul1* genes.

Data availability. {#s1.1}
------------------

This whole-genome shotgun project is deposited at DDBJ/ENA/GenBank under the accession numbers listed in [Table 1](#tab1){ref-type="table"}, and the SRA submission of raw data (FastQ format) is recorded under the accession number [PRJNA312617](https://www.ncbi.nlm.nih.gov/sra/PRJNA312617).
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